NDC 17856-0620-01 - Baclofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0620
- Requested NDC
- 17856-0620-01
- Package NDCs from labels
- 17856-0620-1, 17856-0620-2, 17856-0620-3, 17856-0620-4, 17856-0620-5, 17856-0620-9, 17856-0620-01
- Manufacturer
- Atlantic Biologicals Corp.
- Effective date
- 2026-09-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Baclofen - Atlantic Biologicals Corp. | Atlantic Biologicals Corp. | 2026-09-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0620-1 | Baclofen | 2.5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 2.5 | 2 | |
| 17856-0620-1 | Baclofen | 72 in 1 CASE | SOLUTION | 72 | 2 | |
| 17856-0620-2 | Baclofen | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 2 | |
| 17856-0620-2 | Baclofen | 72 in 1 CASE | SOLUTION | 72 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Baclofen | BACLOFEN | A-S Medication Solutions | 5f6a86f9-9658-4210-a47c-62907edfd416 | 2026-03-19 | Warnings, Adverse reactions | H789N3FKE8 |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | 059QF0KO0R |
| BACLOFEN | BACLOFEN | Preferred Pharmaceuticals Inc. | 5e479876-adfb-4590-ac10-3924ff7988b0 | 2026-03-18 | Warnings, Adverse reactions | H789N3FKE8 |
| BACLOFEN | BACLOFEN | Preferred Pharmaceuticals Inc. | 3fdfeef9-68b3-4f6c-a4de-28179758a962 | 2026-03-18 | Warnings, Adverse reactions | H789N3FKE8 |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| Baclofen | BACLOFEN | Redpharm Drug | 4ce1de84-72e1-57d3-e063-6294a90a220f | 2026-03-13 | Warnings, Adverse reactions | H789N3FKE8 |
| OZOBAX DS | BACLOFEN | Rosemont Pharmaceuticals LLC | d8ddcec5-debe-42b4-a803-e65917cc6a54 | 2026-03-13 | Warnings, Adverse reactions | NDA208193 2667941 H789N3FKE8 |
| Optimel Manuka Dry Eye Drops | GLYCERIN | Melcare Biomedical Pty Ltd | 88c5e2f0-9f7e-62d1-e053-2995a90a9014 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Optimel Manuka Forte Eye Gel | GLYCERIN | Melcare Biomedical Pty Ltd | 8e0ed6e8-51fc-7c5b-e053-2a95a90a35a9 | 2026-03-11 | Warnings | PDC6A3C0OX |
| Fleet | GLYCERIN | C.B. Fleet Company, Inc. | 31778652-e60e-4098-8e90-3e4f56b5800c | 2026-03-06 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 4c6094b7-c1ef-26a3-e063-6394a90af4cc | 2026-03-06 | Warnings | PDC6A3C0OX |
| 2-Pack Facial Serum | 2-PACK FACIAL SERUM | Guangzhou Ariel Biotech Co., Ltd. | 27c7f645-cfb3-6db1-e063-6394a90a42ff | 2026-03-06 | Warnings | 059QF0KO0R |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-03-06 | Warnings | PDC6A3C0OX |
| Dry Eye Relief Sterile Lubricant Eye Drops | GLYCERIN | Similasan Corporation | 4c4cce1c-392e-354d-e063-6294a90a0ca3 | 2026-03-05 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | CVS PHARMACY, INC | 9683bcfb-2f7e-48a4-aa79-500ee8df099a | 2026-03-02 | Warnings | PDC6A3C0OX |
| Refresh Optive Mega-3 PF | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | 326cb5d6-c784-404f-9a13-6d69262dda6e | 2026-03-01 | Warnings | PDC6A3C0OX |
| Baclofen | BACLOFEN | Lifestar Pharma LLC | f9dd1b55-2984-446a-8146-2ab0f5211e15 | 2026-02-27 | Warnings, Adverse reactions | H789N3FKE8 |
| Dermatool Hemorrhoidal | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Papalo Group LLC | 4bc06f41-7733-ebd0-e063-6294a90af7a8 | 2026-02-26 | Warnings | PDC6A3C0OX |
| Baclofen | BACLOFEN | A-S Medication Solutions | 7ee42a29-21c2-47f8-a5b3-f3af115b665d | 2026-02-24 | Warnings, Adverse reactions | H789N3FKE8 |
| BACLOFEN | BACLOFEN | Major Pharmaceuticals | 46f84504-ffc4-4be5-9598-c20a3f4210f4 | 2026-02-13 | Warnings, Adverse reactions | H789N3FKE8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.